GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM102068
Query DataSets for GSM102068
Status
Public on Mar 30, 2006
Title
YUMAC
Sample type
RNA
Source name
metastatic melanoma culture
Organism
Homo sapiens
Characteristics
Gender: male
Extracted molecule
polyA RNA
Label
biotin
Description
Culture was made from a recurrent metastasis at the site of excision.
Data processing
MAS5.0
Submission date
Mar 29, 2006
Last update date
Mar 29, 2006
Contact name
Keith S Hoek
E-mail(s)
keith.hoek@usz.ch
URL
http://www.jurmo.ch/work.html
Organization name
Currently unaffilliated
Street address
private
City
Zürich
ZIP/Postal code
8004
Country
Switzerland
Platform ID
GPL96
Series (1)
GSE4570
Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas.
Data table header descriptions
ID_REF
VALUE
Scaled signal intensity data
ABS_CALL
Detection call: Present (P), Marginal (M) or Absent (A)
DETECTION P-VALUE
Significance of the detection call
Data table
ID_REF
VALUE
ABS_CALL
DETECTION P-VALUE
AFFX-BioB-5_at
267.2
P
0.016469
AFFX-BioB-M_at
625.7
P
0.001113
AFFX-BioB-3_at
286.5
P
0.006187
AFFX-BioC-5_at
1000.7
P
0.000225
AFFX-BioC-3_at
729.9
P
0.000225
AFFX-BioDn-5_at
901.7
P
0.000195
AFFX-BioDn-3_at
5748.9
P
0.000509
AFFX-CreX-5_at
7152.2
P
0.000066
AFFX-CreX-3_at
11044.9
P
0.000044
AFFX-DapX-5_at
57.5
M
0.063107
AFFX-DapX-M_at
30.6
A
0.48511
AFFX-DapX-3_at
3.8
A
0.971543
AFFX-LysX-5_at
25.9
A
0.205732
AFFX-LysX-M_at
31.9
A
0.51489
AFFX-LysX-3_at
27.4
A
0.389089
AFFX-PheX-5_at
6
A
0.749204
AFFX-PheX-M_at
8
A
0.794268
AFFX-PheX-3_at
22.2
A
0.749204
AFFX-ThrX-5_at
9
A
0.937071
AFFX-ThrX-M_at
45.1
A
0.273044
Total number of rows:
22283
Table truncated, full table size
592 Kbytes
.
Supplementary data files not provided
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|
